Sponsored by:

Nuclear Medicine: Page 270

PET/CT cost-effective for head, neck squamous cell carcinoma
By Wayne Forrest
FDG-PET/CT is not only most effective for pretreatment screening of distant metastases in patients with head and neck squamous cell carcinoma, the combined modalities do so with no additional costs to healthcare providers, according to researchers in the Netherlands.
February 16, 2010
MDS inks deals to sell Pharma Services units
By AuntMinnie.com staff writers
MDS has agreed to sell its Pharma Services early-stage business for $45 million and minority equity positions.
February 11, 2010
Peregrine touts Cotara study
By AuntMinnie.com staff writers
A new study shows that brain cancer patients treated with Peregrine Pharmaceuticals' Cotara agent experience long-term survival.
February 10, 2010
Principio inks deal with Johns Hopkins
By AuntMinnie.com staff writers
Radiopharmaceutical developer Principio has inked a license agreement for several molecular imaging agents and therapeutic radiopharmaceuticals developed at Johns Hopkins Sidney Kimmel Comprehensive Cancer Center in Baltimore.
February 10, 2010
Pediatric cancer risk from thallium imaging defined
By Cynthia E. Keen
Researchers from a Tennessee children's hospital have found that thallium-based bone nuclear imaging studies can raise the risk of cancer incidence in pediatric patients, according to an article in the January issue of the American Journal of Roentgenology.
February 10, 2010
Zecotek signs Shinshu
By AuntMinnie.com staff writers
Nuclear medicine firm Zecotek Photonics said that Shinshu University has selected its lutetium fine silicate (LFS) scintillation crystals for trials in their PET imaging development program.
February 9, 2010
Endicott forms imaging unit
By AuntMinnie.com staff writers
Endicott Interconnect Technologies has launched a detection and imaging systems business unit.
February 9, 2010
Study to compare 320-row CT perfusion against SPECT
By Eric Barnes
Following up on the CORE 64 study that tested the value of coronary CT angiography vis-à-vis angiography, researchers have launched a new international trial to compare 320-detector-row CT perfusion to SPECT myocardial perfusion imaging for detecting early coronary artery disease.
February 9, 2010
Zero calcium score enough to send chest pain patients home
By Eric Barnes
Patients presenting to the emergency room with chest pain who have zero calcium scores on cardiac CT probably can be discharged with a low likelihood of adverse events on follow-up, according to a study published online February 8 in the Annals of Emergency Medicine.
February 9, 2010
FDA launches initiative to rein in medical radiation
By Cynthia E. Keen
The U.S. Food and Drug Administration this week announced an initiative to reduce unnecessary radiation exposure from CT, fluoroscopy, and nuclear medicine exams. The move is widely believed to be in response to reports of rising exposure to medical radiation in the U.S. population.
February 8, 2010
2009 11 12 17 39 08 655 2009 03 02 Radioactive Symbol
UltraSPECT launches new protocol
By AuntMinnie.com staff writers
Nuclear medicine firm UltraSPECT has launched a new protocol for its Xpress3.Cardiac software.
February 8, 2010
Stress perfusion CT adds value to coronary CT angiography
By Eric Barnes
Combined stress perfusion CT imaging not only is feasible, it's potentially valuable for assessing some patients at risk of coronary artery disease in a one-modality imaging procedure, according to a study appearing this month in Radiology.
February 8, 2010
2010 02 05 17 53 28 634 Rocha Thumb
Previous Page
Page 270 of 437
Next Page